[Change in vascular endothelial growth factor level in serum and urine of esophageal carcinoma patients].
The purpose of this study was to determine the serum and urine vascular endothelial growth factor (VEGF) level in patients with esophageal carcinoma and to elucidate their significance of pre-operative VEGF levels. Urine VEGF level was measured by sandwich ELISA in 82 esophageal carcinoma patients and 15 healthy individuals. The serum and urine VEGF levels (mean +/- s, ng/L) in esophageal carcinoma patients were 92.81 +/- 5.86 and 277.92 +/- 22.71 which were significantly higher than those of healthy subjects (16.01 +/- 3.46 and 15.27 +/- 4.22, P < 0.01). The pre-operatiive urine VEGF level in esophageal cancer patients were significantly higher in advanced stage of the disease (P < 0.01). As to the depth of invasion (T-factor), the urine VEGF level of T4 invasive lesions were significantly higher than those with T1-T3 invasion (P < 0.01). The same was also true in esophageal carcinoma having lymph node metastasis than that without (P < 0.05). The urine VEGF level was significantly higher than the serum VEGF level (P < 0.01). VEGF plays an important role in the growth and metastasis of esophageal cancer.